$FULC
Fulcrum Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
FULC chart
What traders are saying about $FULC
Latest postsFulcrum Therapeutics, Inc. news
- BlackRock reports sole voting power over 5.44M shares in its amended Fulcrum Therapeutics (FULC) stake disclosure.
Stock Titan ·
- Spero Therapeutics names two executives, COO to retire
StreetInsider ·
- Fulcrum Therapeutics, Inc. Estimates – NASDAQ:FULC
TradingView ·
- Fulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
TradingView ·
- Slate Medicines Starts Migraine Treatment Study
Yahoo Finance ·
- Fulcrum (FULC) is Allocating 95% of the Combined Company to Slate and PIPE Investors. Is the $270M Dividend Enough?
Yahoo Finance ·
- Fulcrum and Slate Medicines sign merger agreement
pharmaceutical-technology.com ·
- Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies
Yahoo Finance ·
- Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal
marketbeat.com ·
- Fulcrum Therapeutics, Slate Medicines to Combine in All-Stock Merger
Yahoo Finance ·
- Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
Yahoo Finance ·
- Slate, Fulcrum to combine in reverse merger
biopharmadive.com ·
Fulcrum Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$74.9M | -$9.7M | -$97.3M | -$109.9M |
| Diluted EPS | $-1.18 | $-0.16 | $-1.59 | $-2.44 |
| Total assets (year end) | $366.3M | $260.7M | $257.7M | $226.7M |
| Cash and equivalents (year end) | $197.5M | $58.2M | $25.6M | $35.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Fulcrum Therapeutics, Inc.
- Ticker
- FULC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1680581
Frequently asked questions
What exchange is Fulcrum Therapeutics, Inc. listed on?
Fulcrum Therapeutics, Inc. trades on the Nasdaq under the ticker symbol FULC.
What industry is Fulcrum Therapeutics, Inc. in?
Fulcrum Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Fulcrum Therapeutics, Inc. headquartered?
Fulcrum Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Fulcrum Therapeutics, Inc.'s fiscal year end?
Fulcrum Therapeutics, Inc.'s fiscal year ends on December 31.